Pipelinepharma

Pipelinepharma is a platform dedicated to CTD dossier market intelligence and sourcing. It connects pharmaceutical companies globally, offering a seamless way to access high-quality dossiers and strategic partnerships. For sellers, including CTD dossier owners and pharmaceutical manufacturers, Pipelinepharma provides an efficient route to reach qualified distributors, enabling licensing and supply agreements while expanding into new markets. Buyers, such as pharmaceutical companies, distributors, and pharmacy chains, benefit from a subscription service that grants direct access to over 2,000 qualified CTD owners and CDMOs. The platform also provides free access to a vast repository of more than 85,000 CTD dossiers. Pipelinepharma stands out by eliminating the need for intermediaries or brokerage fees, facilitating a direct connection between buyers and sellers. The company recently secured a €1.30M Seed Round investment on 31 May 2021 from Practica Capital, Rockstart Accelerator, Iron Wolf Capital, Pandora. With its mission to create a transparent, efficient pharmaceutical marketplace, Pipelinepharma aims to empower businesses to grow and innovate, driving access to essential medicines worldwide.